Up next

Autoplay

Dr. Mesa on Ruxolitinib in Chronic Myeloid Leukemia

1 Views • 07/08/23
Share
Embed
administrator
administrator
Subscribers
0

Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the mechanism of action of ruxolitinib in chronic myeloid leukemia.

More on hematologic malignancies: http://www.onclive.com/special....ty/hematologic-cance

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay